优质高产紫花苜蓿新品种CW 400

CW 400系宁夏固原市农科所2000年从美国西海岸种子公司引入,通过多年多点试验、鉴定,2006年经宁夏回族自治区农作物品种审定委员会审定推广,适宜干旱半干旱地区种植.     

国内高架桥绿化及研究现状

从高架桥区的生态环境、适生种类的选择以及高架桥绿化的养护管理、景观配置模式四个方面对国内的高架桥绿化及研究现状进行了分析和探讨,指出了存在的问题和解决方法,并对高架桥绿化的前景进行了展望.     

30 000 m3干式气柜不安全问题与改进

从密封结构、柜顶钢板、密封油质、闪点等方面分析了30 000 m3稀油密封干式气柜在运行中存在的问题,提出了相应的改进措施和建议.经大修改造,有效提高了30 000 m3稀油密封干式气柜的运行周期,延长了使用寿命.     

低档计算机的合理再利用

本文介绍厂一种通过将Windows 2000 Server的终端服务功能和第3方软件的有机结合，把低档计算机(286、386等)作为Windows 2000 Server服务器的终端，在终端上运行Windows 2000，Officc2000、PhotoShop、C语言、PAPAL语言等常用软件和下具的低档计算机再利用的方法。     

青海省草地畜牧业可持续发展对策

概括目前青海省草地畜牧业经营状况 ,探讨草地不断退化、畜牧业经营效益居后的原因 ;结合当地气候、地理和资源特征提出了一些可持续发展举措 ,为提高草地畜牧业的经济效益和可持续发展能力提供一些参考     

明清实学思潮的理论创新与本体论特点

从明中晚期到鸦片战争前后的本体论学说主要表现为对宋明道学本体论的批评和对新的本体论形态的探求。犹如西方哲学史中本体论的现当代转化一样 ,思想家们在扬弃“道”、“理”、“心”等僵化的本体过程中 ,力图对相当于海德格尔的“此在”的“主体”进行界定。他们不把本体当作圆满的先验预设 ,认为道德学首先应该使自身成为知识学。这种本体论思想的出现标志着中国本体思想的近代转化     

集约化养猪场猪咬尾症的发生和防治

在集约化养猪生产中，常可见到猪的咬尾症，严重影响猪的健康和生产性能。引起猪咬尾症的原因是多方面的，而且往往是几种因素同时作用，且发生于不同的饲养阶段。可见防制猪咬尾症的措施应是综合性的，并应贯穿于养猪生产的始终。本文分析了猪咬尾症发生的原因，介绍了猪咬尾症的防治措施。     

甜菜种质资源数量性状遗传距离差异及其应用的研究

对60份参试材料的5个性状主成分分析结果表明,确定甜菜主成分因子有根产量、含糖量和抗褐斑病性;聚类分析结果,按类群间遗传距离大于类群内遗传距离的原则分为6类.类群间的平均遗传距离(?)~2=16.781,大于该平均遗传距离的类群组合有Ⅰ和Ⅳ,Ⅰ和Ⅴ,Ⅰ和Ⅵ,Ⅱ和Ⅵ,Ⅲ和Ⅴ,Ⅲ和Ⅵ,在上述类群间选择亲本有效.     

Stereoselective degradation of ethofumesate in turfgrass and soil

The stereoselective degradation of ethofumesate in turfgrasses and several agricultural soils was investigated to provide details of the fate of this chiral herbicide. Racemic ethofumesate was either foliar applied to two species of turfgrass or fortified into four types of agricultural soils. (+)- and (−)-Enantiomers were extracted and analyzed by a validated chiral HPLC method which involved extraction of samples with organic solvent followed by separation on cellulose-Tris-(3,5-dimethylphenylcarbamate)-based chiral column and quantification by UV absorbance at 230 nm. Mean recoveries of each enantiomer fortified at 0.5, 5, and 10 μg g⁻¹ ranged from 82.3 ± 5.84 to 92.5 ± 2.87% in turfgrasses and from 86.0 ± 5.09 to 98.1 ± 2.51% in soil. As a measure of this composition, the enantiomeric ratio (ER) was used, defined as the concentration ratio of (+)/(−)-enantiomer. Similarly, preferential degradation of the (−)-enantiomer was observed in both grass species with the largest ER of about 3 and in one of the test soil with ER = 1.65, resulting in residues enriched with (+)-enantiomer. This stereoselective degradation in this soil led to significant difference on half-lives between the two enantiomers. No stereoselective degradation was observed in other soils.     

Selection and amplification of the liver stem cell subset from rat bone marrow cells with a medium containing cholestatic serum in vitro

AIM: To explore the feasibility of direct separat and selective enlargement of the bone marrow-derived liver stem cells (BDLSC) from bone marrow cells with a culture system containing cholestatic serum in vitro. METHODS: Bone marrow cells of rats were cultured with selective media containing 2%, 5%, 7% and 10% cholestatic rat serum, respectively. The BDLSC were then induced to proliferate with the addition of hepatocyte growth factor (HGF) on the firth day. BDLSC were characterized using immunocytochemistry and RT-PCR for lineage markers, glycogen staining and urea synthetic assay for functions 2 weeks later. RESULTS: Bone marrow cells were unble to form colony in the presence of 2% cholestatic serum and apopotosis appeared gradually in 7% or 10% cholestatic serum. The BDLSC survived in the medium containing 5% cholestatic serum while the other types of cells did not. The survival cells proliferated with a high speed during the second week and then formed hepatocyte-like colony-forming units (H-CFU). Cells in the H-CFU expressed the characteristic proteins of fetal hepatocytes. Furthermore, they had glycogen storage and urea synthesis functions, two of the critical features of hepatocytes. CONCLUSION: The selective micro-environment effectively selected BDLSC from the bone marrow cell, and will be a new way to provide an abundant source of donor hepatocytes for clinical cell therapy.